Opko Health, Inc. Business Finance Contracts & Agreements

53 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Amended 5% Convertible Promissory Note dated February 10, 2023
Note Agreements
Opko Health, Inc.
Biotechnology
NY
2023
Waiver Under and Amendment No. 1 to Amended and Restated Credit Agreement, dated as of April 29, 2022, by and among BioReference Health LLC, GeneDx, LLC, the other subsidiary...
Loan Agreements
Opko Health, Inc.
Biotechnology
NJ
2022
Asset Purchase Agreement, dated June 16, 2021, among EirGen Pharma Limited, Horizon Therapeutics Ireland DAC, and OPKO Health, Inc. (with respect to certain sections)
Purchase Agreements
Opko Health, Inc.
Biotechnology
DE
2021
Form of Exchange Agreement, dated as of May 6, 2021, by and between OPKO Health Inc. and the applicable Noteholder
Exchange Agreements
Opko Health, Inc.
Biotechnology
NY
2021
Amendment No. 12 to Credit Agreement, dated as of March 12, 2021, by and among BioReference Laboratories, Inc., certain of its subsidiaries, and JPMorgan Chase Bank, N.A
Credit Agreements
Opko Health, Inc.
Biotechnology
FL
2021
Credit Agreement, dated as of February 25, 2020, by and between OPKO Health, Inc. and Frost Gamma Investment Trust
Credit Agreements
Opko Health, Inc.
Biotechnology
FL
2020
Amendment No. 11 to Credit Agreement by and between BioReference Laboratories, Inc. and certain of its subsidiaries, and JPMorgan Chase, N.A. dated February 25, 2020
Credit Agreements
Opko Health, Inc.
Biotechnology
FL
2020
Amendment No. 10 to Credit Agreement by and between BioReference Laboratories, Inc. and certain of its subsidiaries, and JPMorgan Chase, N.A. dated November 4, 2019
Credit Agreements
Opko Health, Inc.
Biotechnology
NY
2020
Amendment No. 9 to Credit Agreement by and between BioReference Laboratories, Inc. and certain of its subsidiaries, and JPMorgan Chase, N.A. dated August 6, 2019
Credit Agreements
Opko Health, Inc.
Biotechnology
FL
2019
Underwriting Agreement, dated February 4, 2019, by and between the Company and Jefferies LLC
Underwriting Agreements
Opko Health, Inc.
Biotechnology
NY
2019
Amendment No. 8 to Credit Agreement by and between BioReference Laboratories, Inc. and certain of its subsidiaries, and JPMorgan Chase, N.A. dated February 26, 2019
Credit Agreements
Opko Health, Inc.
Biotechnology
FL
2019
Stock Purchase Agreement, dated as of November 8, 2018, between certain investors and OPKO Health, Inc
Stock Agreements
Opko Health, Inc.
Biotechnology
FL
2019
Credit Agreement, dated as of November 8, 2018, by and between the OPKO Health, Inc. and Frost Gamma Investments Trust
Credit Agreements
Opko Health, Inc.
Biotechnology
FL
2019
Share Lending Agreement, dated February 4, 2019, by and between the Company and Jefferies Capital Services, LLC
Share Agreements
Opko Health, Inc.
Biotechnology
NY
2019
Form of 4.50% Convertible Senior Notes due 2025 (incorporated herein by reference to Exhibit A of the First Supplemental Indenture filed as Exhibit 4.3 to this Current Report on...
Indenture Agreements
Opko Health, Inc.
Biotechnology
DE
2019
Base Indenture related to the 4.50% Convertible Senior Notes due 2025, dated as of February 7, 2019, by and between the Company and U.S. Bank National Association, as trustee
Indenture Agreements
Opko Health, Inc.
Biotechnology
DE
2019
Underwriting Agreement, dated February 4, 2019, by and between the Company and Jefferies LLC
Underwriting Agreements
Opko Health, Inc.
Biotechnology
NY
2019
Amendment No. 7 to Credit Agreement by and between BioReference Laboratories, Inc. and certain of its subsidiaries, and JPMorgan Chase, N.A. dated February 28, 2018
Credit Agreements
Opko Health, Inc.
Biotechnology
FL
2018
Form of 5% Convertible Promissory Note dated February 27, 2018
Note Agreements
Opko Health, Inc.
Biotechnology
NY
2018
Amendment No. 6 to Credit Agreement, dated as of December 22, 2017, among Bio-Reference Laboratories, Inc. and certain of its subsidiaries and JPMorgan Chase Bank, N.A
Credit Agreements
Opko Health, Inc.
Biotechnology
NY
2018
Amendment No. 5 to Credit Agreement, dated as of November 8, 2017, among Bio-Reference Laboratories, Inc. and certain of its subsidiaries and JPMorgan Chase Bank, N.A
Credit Agreements
Opko Health, Inc.
Biotechnology
NY
2018
Amendment No. 4 to Credit Agreement by and between Bio-Reference Laboratories, Inc. and certain of its subsidiaries and JPMorgan Chase Bank, N.A. dated August 7, 2017
Credit Agreements
Opko Health, Inc.
Biotechnology
FL
2017
AMENDMENT NO. 3 TO CREDIT AGREEMENT
Credit Agreements
Opko Health, Inc.
Biotechnology
FL
2017
CREDIT AGREEMENT dated as of November 5, 2015, among BIO-REFERENCE LABORATORIES, INC., as the Company, The Subsidiaries from time to time party hereto as Subsidiary Borrowers, The...
Loan Agreements
Opko Health, Inc.
Biotechnology
NY
2016
DATED 5 May 2015 (1) SELLERS (2) OPKO IRELAND LIMITED FORM OF AGREEMENT FOR THE SALE AND PURCHASE OF SHARES IN EIRGEN PHARMA LIMITED McCann FitzGerald Solicitors Riverside One Sir...
Purchase Agreements
Opko Health, Inc.
Biotechnology
2015
DATED 5 May, 2015 (1) SELLERS (2) OPKO IRELAND LIMITED (3) OPKO HEALTH, INC. AGREEMENT FOR THE SALE AND PURCHASE OF SHARES IN EIRGEN PHARMA LIMITED McCann FitzGerald Solicitors...
Purchase Agreements
Opko Health, Inc.
Biotechnology
FL
2015
SHARE PURCHASE AGREEMENT BY AND AMONG CYTOCHROMA INC., CYTOCHROMA HOLDINGS ULC, CYTOCHROMA CANADA INC. CYTOCHROMA DEVELOPMENT INC. PROVENTIV THERAPEUTICS, LLC CYTOCHROMA CAYMAN...
Share Agreements
Opko Health, Inc.
Biotechnology
DE
2013
OPKO HEALTH, INC. 3.00% CONVERTIBLE SENIOR NOTES DUE 2033 INDENTURE DATED AS OF JANUARY 30, 2013 WELLS FARGOBANK, NATIONAL ASSOCIATION TRUSTEE Table of Contents
Indenture Agreements
Opko Health, Inc.
Biotechnology
DE
2013
NOTE PURCHASE AGREEMENT
Note Agreements
Opko Health, Inc.
Biotechnology
NY
2013
STOCK PURCHASE AGREEMENT
Stock Agreements
Opko Health, Inc.
Biotechnology
2012
STOCK PURCHASE AGREEMENT
Stock Agreements
Opko Health, Inc.
Biotechnology
FL
2012
ASSET PURCHASE AGREEMENT
Purchase Agreements
Opko Health, Inc.
Biotechnology
DE
2011
FORM OF RESTRICTED STOCK AGREEMENT FOR DIRECTORS
Stock Agreements
Opko Health, Inc.
Biotechnology
FL
2009
COMMON STOCK WARRANT
Warrant Agreements
Opko Health, Inc.
Biotechnology
DE
2009
SECURITIES PURCHASE AGREEMENT dated as of September 18, 2009 by and among OPKO HEALTH, INC. AND THE PURCHASERS SET FORTH ON THE SIGNATURE PAGES HERETO
Purchase Agreements
Opko Health, Inc.
Biotechnology
FL
2009
STOCK PURCHASE AGREEMENT
Stock Agreements
Opko Health, Inc.
Biotechnology
FL
2008
CONFIDENTIAL MATERIAL OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSIONS. SECURITIES PURCHASE AGREEMENT
Exchange Agreements
Opko Health, Inc.
Biotechnology
FL
2008
STOCK PURCHASE AGREEMENT
Stock Agreements
Opko Health, Inc.
Biotechnology
2008
OPKO HEALTH, INC. - and - OTI HOLDINGS LIMITED - and - EACH HOLDER OF EXCHANGEABLE SHARES in the capital of OTI Holdings Limited EXCHANGE AND SUPPORT AGREEMENT DATED: November 28,...
Exchange Agreements
Opko Health, Inc.
Biotechnology
2008
SHARE PURCHASE AGREEMENT November 28, 2007
Share Agreements
Opko Health, Inc.
Biotechnology
2008